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1001-110 impact of Time to Reperfusion on Microvascular 
Damage After Primary Coronary Angioplasty for Acute 
Myocardial Infarction 
Takefumi Takahashi. Yoshikazu Hiasa, Takeshi Tomokane, Koji Yamaguchi, Riyo 
Oaura. Yoshikazu Ohara. Kanii Kusunoki. Kenichiro Yuba. Tatsuro Oaata. Shinobu 
1  
Hosokawa, Koichl Kishi, Ryuji Ohtani. Tokushima Red Cross Hospital, Komatsushima, 
Japan 
Backgrounds: A distinctive coronary flow velocity (CFV) pattern characterized by dimin- 
ished systolic antegrade flow and rapid diastolic deceleration rate (DDR) is thought to 
reflect a greater degree of microvascular damage in the risk area. We evaluated the 
impact of time to reperfusion on mlcrovascular damage after primary coronary angio- 
plasty for acute myocardlal infarction (AMI). 
Methods: We studied 73 patients with a first anterior wall myocardial infarction, without 
cardiogenic shock, who underwent primary coronary angioplasty within 12 hours (h) of 
onset. CFV parameters were assessed immediately after reperfusion using a Doppler 
guidewire. We measured systolic velocity integral (SVI) and DDR as makers of microvas- 
cular damage, according to the previous studies. 
Results: Reperfusion was achieved within 2 h in 9 patients (12%). SVI was significantly 
higher in patients with early reperfusion (~2 h vs. 4 to <6h and >/=6h, P = 0.003). Peak 
CPK was signtficantly lower in patients with early reperfusion (~2 h vs. 2 to c4 h, 4 to 
c6h. and >/=6h, P = 0.002). There were no differences in other clinical characteristtcs by 
time to repelfusion. 
Conclusions: Time to reperfusion, wcthln 2 h, is important for preventmg microvascular 
damage, which results in reduced infarct size. However, after 2 h, mkxovascular damage 
after primary coronary angioplasty is not dependent on time to reperfusion in patients 
with antenor AMI. 
CFV panmeters and chical results by tune to repefision 
<2h 2 to <4h 4 to <6h P value 
>/=6h 
(n=9. 12%) (n=36, 52%) (n=l3, 16%) (n=13, 16%) 
SVI, cm 3.6*1.7 2.2i2.6 0.5+1.&l 0.4i2.1 0.003 
DDR. cm/s& 37*19 126*101 139i132 143kl22 NS 
Peak CPK, IV/L 2041*1229 5402+2374 5500*3011 4667+1777 0.002 
LVEFat IM. % 66+10 53tll 55+15 54*11 0.04 
1001-111 Use of Glycoprotein llb/llla Receptor Blockers Before 
and During Percutaneous Coronary Intervention for 
Acute Coronary Syndromes Versus Stable Angina in 
Consecutive Patients in Europe: Results of the 
International SHAKESPEARE Registry 
Anselm K. Gitt, Martin G. Gottwik, Ricardo Seabra-Games, Jean-Pierre L. Bassand, 
Paolo Fioretti, David Hashdai, Keith Dawkins, Karl E. Siegler, Rudolf Schiele, Uwe 
Zeymer, Jochen Senges, SHAKESPEARE-Study-Group, Heruentrum Ludwigshafen, 
Ludwigshafen, Germany 
Background: In early 2001, the ACCIAHA Task Force on Practice Guidelines published 
revised guidelines for percutaneous coronary interventions (PCI). At this time, no data 
exist to help understand how these guidelines are implemented into clinical practice, 
especially the use of GP Ilb/llla receptor blockers (Ilb/llla). The SHAKESPEARE REGIS- 
TRY has been designed to fill this informational void. 
Methods: Since February 2002 consecutive patients undergoing PCI have been included 
in the International SHAKESPEARE tegistty to document clinical practice in 30 centers in 
different countries of the European Society of Cardnlogy (France, Germany, Israel, Italy, 
Portugal, UK). 
Results: Out of 3.117 consecutive patients undergoing PCI 1,796 patients (56%) had 
acute coronary syndromes (ACS), 19.5% acute STEMI, 7.6% acute NSTEMI, 30.3% 
unstable angIna, 1,251 patients (42%) underwent PCI for stable angma. Ilb/llla were 
given in 46% of the ACS patients and in 26% of the patients with stable angina. In 
patients with stable angina llblllla was given because the patients were considered high 
risk or because of technical difficult PCI. 
Conclusion: The use of llbillla was high in consecutive patients undergoing PCI for ACS 
with 22% even before the start of the intervention and 46% during the procedure. In con- 
secutwe patients undergoing PCI for stable angina Ilb/llla was given in only a minority 
before the intervention but in more than one quarter of the patients during the PCI proce- 
dure. 
Age (yean) 
Male gender 
Prior MI 
GP Ilb/llla before PCI 
Abclximab 
ACS 
(Il=1,798) 
64 
74.8 % 
19.9 % 
22.1 % 
7.4 % 
Stable Angina 
(n=l,251) 
64 
76.1 % 
32.4 % 
3.5 % 
1.3% 
P 
“s 
<O.Ol 
<O.Ol 
co.01 
co.01 
Tlrofiban 
3.7 % 0.9 % <O.Oi 
Eptifibatide 
10.9 % 1.8% co.01 
GP Ilb/llla during PCI 
Abciximab 
46.1 % 26.2 % co.01 
21.2 % 14.3 % co.01 
Tirofiban 
a.2 % 1.4% <O.Ol 
Eptifibatide 
10.7 % 6.3 % <O.Ol 
Stent 
Bleeding complication 
Hospital mortality 
75.7 % 74.6 % “s 
6.5 % 5.9 % <O.Ol 
2.9 % 0.4 % co.01 
1001-112 Prognostic Value of the Absolute Degree of ST-Segment 
Elevation of the ECG at Baseline and After Primary 
Angioplasty: Analysis From the CADILLAC Trial 
Eve D. Avmonq Michael G. McLaughlin, Peter Zimetbaum. Cindy L. Grines, James E. 
Tcheng, David A. Cox. Thomas D. Stuckey, Mark Turco, Eulogia Garcia, John J. Griffin. 
Roxana Mehran. Gregg W. Stone, The CADILLAC Investigators, Cardiovascular 
Research Foundation, New York, NY 
Background: In pts with AMI undergoing reperfusion therapy, ST-segment resolution 
(STR), as calculated by relative reduction of ST elevation (STE) from the pre to the post 
reperfusion ECG, has been found to correlate strongly with survival. Whether the &so- 
lute degree of STE on the pre and post ECG is prognostically important is undetermined. 
Methods: In CADILLAC, 2,062 pts were prospectively randomized to PTCA vs. stenting, 
each + abciximab. Paired ECGs withln 4 hours pre and post PCI with >l mm baseline 
STE without bundle branch block, paced rhythm, ectopy, missing leads or artifact were 
available in 700 patients and analyzed by an independent core ECG laboratory. 
Results: LAD infarction and lower baseline LVEF (p=O.Ol) were both associated with 
greater degrees of STE on the pre and post EGG. Additional correlates of residual STE 
on the post procedure ECG alone included hypertension, 3 vessel ds.. smaller reference 
vessel diameter, larger balloon to artery ratio, and pre and post TIMI O/l flow (~~0.05 for 
all). The incidence and impact of different degrees of pre and post PCI STE of l-year 
mortality appear in the table. 
Conclusions: The magnitude of ST elevation pre and post PCI are both strongly and 
continuously predictive of late modality after percutaneous intervention for AMI. In partic- 
ular, >2 mm of STE on the post PCI ECG (present I” nearly 1 in 6 pts) is a particularly 
ominous finding. The extent of STE should be considered when assessing baseline risk 
and the results of therapeutic interventions for AMI. 
STE pra PCI 
Incidence 
1 -year mortality 
STE post PCI 
lncldence 
l-year mortality 
1001-113 
<2mm 2to<3mm 3to<4mm 9mm Pvalue 
22% 26% 19% 31% - 
2.6% 3.1% 6.9% 7.5% 0.05 
<OSmm 0.5 to <l mm 1 to<2 mm >2mm P value 
32% 27% 25% 16% - 
3.2% 3.3% 4.6% 12.4% 0.0002 
Improved Efficiency in Both Initial Reperfusion Therapy 
and Subsequent Acute Myocardial Infarction Care 
Through Commitment to Emergency Department- 
Initiated Primary Percutaneous Coronary Intervention 
Jackson L. Thatcher, Theresa A. Gilseth, Susan Adlis, Park Nicollet Heart Center at 
Methodist Hospital, St. LOUIS Park, MN, Park Nicollet Institute, St. Louis Park, MN 
Study objective. Demonstrate improved efficiency of initial and subsequent in-hospital 
care followlng emergency department physician (ED)-initiated prxnary angioplasty 
(1’PCI) in ST-elevation infarction (STEMI). 
Methods. An observational study was undertaken comparing outcomes of patients 
receiving process improvement initiative supported. ED-directed 1’PCI to prior treatment 
by a mix of ED and cardiologist co-determined thrombolysis and I’PCI. 
Results.287 patients were treated. Median door-to-balloon time (MDBT) improved from 
68 to 61 minutes PdJ.0001). Necessary subsequent in-hospital interventions (PC1 or 
CAB) occurred in 65% of thrombolyiic patients, versus 3% of 1’PCI patients, and 1% 
I’PCI patients after process change (PC 0.0001). Median length of stay decreased from 
four days (thrombolytic) and three days (1’PCI) at baseline, to two days (1’PCI) postint- 
erventlon (P<O.OOOl). Improved effectiveness outcomes included beta-blocker: 63% to 
95% @0.0039), angiotensin-converting-enzyme inhibitor: 56% to 66% (P<O.OOOl), and 
antilipid therapy: 68% to 66% (F10.0039). Favorable trends occurred in survival (96.6%) 
